Literature DB >> 8834371

Determination of endotoxin-neutralizing capacity of plasma in postsurgical patients.

D Berger1, S Ott, U M Schmidt, E Bölke, M Seidelmann, H G Beger.   

Abstract

In 92 patients who underwent abdominal and goiter surgery endotoxin and endotoxin-neutralizing capacity (ENC) were determined in plasma preoperatively and daily postoperatively. Endotoxin plasma levels started to increase on day 1 in patients who were laparotomized. Correspondingly ENC was reduced during the 1st postoperative week. Even on the 1st postoperative day determination of ENC made the differentiation between patients possible who showed an uneventful course and patients who developed pneumonia, pulmonary failure, or mental disorders. Furthermore the need for diuretics in order to maintain sufficient renal function was associated with lower ENC during days 1-3. Endotoxin plasma levels were significantly elevated in patients who developed pneumonia during days 1-4, whereas the occurrence of pulmonary failure was only correlated with elevated endotoxin levels on day 3. Endotoxemia was pronounced in patients needing diuretics on days 1, 4, and 5. In patients who underwent goiter surgery ENC changed significantly as found for endotoxin plasma values during the postoperative course. Determination of endotoxin and especially ENC with the use of the limulus amebocyte lysate test turned out to be a reliable method correlating with impending complications at least in postsurgical patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8834371     DOI: 10.1159/000129450

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  1 in total

1.  Changes in endotoxin-binding proteins during major elective surgery: important role for soluble CD14 in regulation of biological activity of systemic endotoxin.

Authors:  N Hiki; D Berger; M A Dentener; Y Mimura; W A Buurman; C Prigl; M Seidelmann; E Tsuji; M Kaminishi; H G Beger
Journal:  Clin Diagn Lab Immunol       Date:  1999-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.